Danielle Antalffy

Stock Analyst at UBS

(1.24)
# 2041
Out of 5,438 analysts
236
Total ratings
Success rate
Average return
43 Stocks
Name Action PT Current % Upside Ratings Updated
TMCI Treace Medical Conce...
Maintains: Neutral
9 7
6.37 2.04% 7 Aug 8, 2025
RXST RxSight
Maintains: Neutral
16 8
6.64 20.48% 4 Aug 8, 2025
ENOV Enovis
Maintains: Buy
65 57
28.13 102.63% 2 Aug 8, 2025
ZBH Zimmer Biomet Holdin...
Maintains: Sell
91 96
100.02 -4.02% 5 Aug 8, 2025
TNDM Tandem Diabetes Care
Maintains: Neutral
20 17
10.11 68.15% 15 Aug 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
270 230
79.67 188.69% 6 Aug 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
35 24
23.47 2.26% 6 Aug 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
125 134
86.99 54.04% 2 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
105 106
77.88 36.11% 9 Jul 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
130 135
102.78 31.35% 12 Jul 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
547 585
471.96 23.95% 2 Jul 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
180 190
173.87 9.28% 5 Jul 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 58
35.49 63.43% 13 Apr 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
19 17
13.8 17.75% 4 Apr 29, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
85 95
92.75 2.43% 10 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
6 5
4.11 21.65% 2 Jan 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
146 148
131.33 12.69% 12 Jan 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
366 370
376.68 -1.77% 6 Oct 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
90 75
78.21 -4.1% 12 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
218
334.75 -34.88% 4 Sep 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
3
1.36 65.44% 1 Mar 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
160 140
n/a n/a 3 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
300 280
304.75 -8.12% 12 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
975 825
12.41 6547.86% 2 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 20
20 0% 9 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
12 14
14 0% 1 May 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 100
56.07 78.35% 2 May 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 12
8.86 35.44% 3 Mar 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
25 30
38.78 -22.64% 3 Mar 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
60 65
n/a n/a 6 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 45
35.45 26.94% 4 Feb 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
105 85
5.84 1355.48% 10 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
85 95
79.97 18.79% 6 Feb 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
270 275
192.59 42.79% 1 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
345 325
381.02 -14.7% 12 Feb 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Market Perform
36 80
79.13 0.15% 1 Jan 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
26 20
4.61 333.84% 3 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
75 66
27.49 140.09% 4 Nov 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
72 42
7.03 497.44% 7 Nov 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
3
n/a n/a 3 Apr 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
15
1.19 1160.5% 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 75
30.03 149.75% 3 Oct 3, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 1 Aug 22, 2017